These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2480562)

  • 1. Murine myeloid leukemias with aberrant myb loci show heterogeneous expression of novel myb proteins.
    Dudek H; Reddy EP
    Oncogene; 1989 Dec; 4(12):1489-95. PubMed ID: 2480562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Murine myeloid leukemic cells with disrupted myb loci show splicing anomalies that account for heterogeneous sizes in myb proteins.
    Tantravahi R; Dudek H; Patel G; Reddy EP
    Oncogene; 1996 Sep; 13(6):1187-96. PubMed ID: 8808693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional activation potential of normal and tumor-associated myb isoforms does not correlate with their ability to block GCSF-induced terminal differentiation of murine myeloid precursor cells.
    Patel G; Tantravahi R; Oh IH; Reddy EP
    Oncogene; 1996 Sep; 13(6):1197-208. PubMed ID: 8808694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of alternatively spliced transcripts for human c-myb: molecular cloning and sequence analysis of human c-myb exon 9A sequences.
    Dasgupta P; Reddy EP
    Oncogene; 1989 Dec; 4(12):1419-23. PubMed ID: 2687764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of alternate and truncated forms of murine c-myb proteins.
    Ramsay RG; Ishii S; Nishina Y; Soe G; Gonda TJ
    Oncogene Res; 1989; 4(4):259-69. PubMed ID: 2549488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of two translational products for c-myb.
    Dudek H; Reddy EP
    Oncogene; 1989 Sep; 4(9):1061-6. PubMed ID: 2674850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transformation by carboxyl-deleted Myb reflects increased transactivating capacity and disruption of a negative regulatory domain.
    Hu YL; Ramsay RG; Kanei-Ishii C; Ishii S; Gonda TJ
    Oncogene; 1991 Sep; 6(9):1549-53. PubMed ID: 1923521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mml1, a new common integration site in murine leukemia virus-induced promonocytic leukemias maps to mouse chromosome 10.
    Koller R; Krall M; Mock B; Bies J; Nazarov V; Wolff L
    Virology; 1996 Oct; 224(1):224-34. PubMed ID: 8862417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotyping of Evi1, Evi11/Cb2, and Evi12 transformed leukemias isolated from a novel panel of cas-Br-M murine leukemia virus-infected mice.
    Joosten M; Valk PJ; Vankan Y; de Both N; Löwenberg B; Delwel R
    Virology; 2000 Mar; 268(2):308-18. PubMed ID: 10704339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Only late, nonmitotic stages of granulocyte differentiation in 32Dcl3 cells are blocked by ectopic expression of murine c-myb and its truncated forms.
    Bies J; Mukhopadhyaya R; Pierce J; Wolff L
    Cell Growth Differ; 1995 Jan; 6(1):59-68. PubMed ID: 7536440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and mechanism of activation of the myb oncogene.
    Rosson D; Reddy EP
    Gene Amplif Anal; 1986; 4():99-108. PubMed ID: 3333363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The myb oncogene.
    Lipsick JS; Baluda MA
    Gene Amplif Anal; 1986; 4():73-98. PubMed ID: 3333362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternative splicing of the human c-myb gene.
    Westin EH; Gorse KM; Clarke MF
    Oncogene; 1990 Aug; 5(8):1117-24. PubMed ID: 2202948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of c-myb gene regulation in MRL-lpr/lpr mice. Identification of a 5' c-myb nuclear protein binding site and high levels of binding factors in nuclear extracts of lpr/lpr lymph node cells.
    Mountz JD; Steinberg AD
    J Immunol; 1989 Jan; 142(1):328-35. PubMed ID: 2642505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New sites of proviral integration associated with murine promonocytic leukemias and evidence for alternate modes of c-myb activation.
    Mukhopadhyaya R; Wolff L
    J Virol; 1992 Oct; 66(10):6035-44. PubMed ID: 1527851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deregulated c-Myb expression in murine myeloid leukemias prevents the up-regulation of p15(INK4b) normally associated with differentiation.
    Schmidt M; Koller R; Haviernik P; Bies J; Maciag K; Wolff L
    Oncogene; 2001 Sep; 20(43):6205-14. PubMed ID: 11593429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic activation of c-Myb by carboxyl-terminal truncation leads to decreased proteolysis by the ubiquitin-26S proteasome pathway.
    Bies J; Wolff L
    Oncogene; 1997 Jan; 14(2):203-12. PubMed ID: 9010222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of B cell lymphomas by overexpression of a Myb oncogene truncated at either terminus.
    Press RD; Wisner TW; Ewert DL
    Oncogene; 1995 Aug; 11(3):525-35. PubMed ID: 7630637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posttranscriptional regulation of the c-myb proto-oncogene in estrogen receptor-positive breast cancer cells.
    Gudas JM; Klein RC; Oka M; Cowan KH
    Clin Cancer Res; 1995 Feb; 1(2):235-43. PubMed ID: 9815978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of proteins that bind to the leucine zipper motif of c-Myb.
    Favier D; Gonda TJ
    Oncogene; 1994 Jan; 9(1):305-11. PubMed ID: 8302594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.